Ruiz P, Gastaca M, Gonzalez J, Hernandez M J, Ventoso A, Valdivieso A, Montejo M, Ortiz de Urbina J
Transplantation and Liver Surgery Unit, Hospital de Cruces, Barakaldo, Vizcaya, Spain.
Transplant Proc. 2009 Jul-Aug;41(6):2169-71. doi: 10.1016/j.transproceed.2009.06.036.
Postoperative infection is considered one of the most important causes of morbidity and mortality after liver transplantation. We prospectively studied the incidence and significance of infections in preservation solutions for liver transplantation.
From March 2007 to March 2008, we cultured the University of Wisconsin preservation solution for 60 consecutive liver transplantations. Fluid samples were obtained at the beginning and at the end of the back table procedure. Our posttransplant infection prophylactic protocol consisted of ampicillin and cefotaxime for 48 hours.
Cultures were positive in 59 patients (98.4%). Seventy-five percent of the isolates were superficial saprophytic flora (SSF; Staphylococcus coagulase negative, Streptococcus viridans, and Corynebacterium), nevertheless in 15 cases (25.1%) we isolated high virulence pathogens (Staphylococcus aureus, Klebsiella, Escherichia coli, Enterobacter, and Pseudomonas aeruginosa). There were neither anaerobic nor fungal isolates. Sixteen patients (36%) from the group with SSF developed postoperative fever, including 12 with negative posttransplant cultures, while 4 patients showed positive cultures for various microorganisms distinct from those isolated from the preservation solution. Five patients (30%) with high virulence pathogens in the preservation solution developed posttransplant fever, although no pathogen was isolated.
Positive cultures of preservation fluids were observed in 98% of patients, although most of them (75%) were SSF. Microorganisms isolated from posttransplant cultures did not match the ones obtained from the preservation solution. Our results did not support routine culturing of the preservation solution provided that one administrator an adequate posttransplant antibiotic prophylactic regimen.
术后感染被认为是肝移植后发病和死亡的最重要原因之一。我们前瞻性地研究了肝移植保存液中感染的发生率及意义。
2007年3月至2008年3月,我们对连续60例肝移植的威斯康星大学保存液进行培养。在后台操作开始时和结束时获取液体样本。我们的移植后感染预防方案包括使用氨苄西林和头孢噻肟48小时。
59例患者(98.4%)培养结果呈阳性。75%的分离株为浅表腐生菌(SSF;凝固酶阴性葡萄球菌、草绿色链球菌和棒状杆菌),然而在15例(25.1%)中我们分离出了高毒力病原体(金黄色葡萄球菌、克雷伯菌、大肠杆菌、肠杆菌和铜绿假单胞菌)。未分离出厌氧菌和真菌。SSF组中有16例患者(36%)术后发热,其中12例移植后培养结果为阴性,而4例患者培养出与保存液中分离出的微生物不同的各种微生物。保存液中存在高毒力病原体的5例患者(30%)术后发热,尽管未分离出病原体。
98%的患者保存液培养结果呈阳性,尽管其中大多数(75%)为SSF。移植后培养中分离出的微生物与从保存液中获得的微生物不匹配。我们的结果不支持对保存液进行常规培养,前提是给予适当的移植后抗生素预防方案。